Literature DB >> 4085559

Electrophysiological effects of propafenone on isolated guinea-pig ventricular muscle and sheep Purkinje fibres.

J Tamargo, C Delgado.   

Abstract

The electrophysiological effects of propafenone on transmembrane potentials were studied in sheep Purkinje fibres and guinea-pig ventricular muscle. In both preparations propafenone decreased the amplitude and Vmax of the action potential and shifted the resting membrane potential to less negative values. In Purkinje fibres, propafenone also slowed the conduction velocity and shortened the action potential duration whereas in ventricular muscle it had no effect on action potential duration. Propafenone also suppressed: the normal automatic mechanism in Purkinje fibres as well as the automaticity induced by BaCl2 and isoprenaline in ventricular muscle fibres with high resting membrane potential (between -75 mV and -85 mV), the abnormal automatic mechanisms, including the slow action potentials induced by BaCl2 and isoprenaline in ventricular muscle and Purkinje fibres depolarized above -55 mV, respectively, and the delayed after-depolarizations induced by ouabain in Purkinje fibres and ventricular muscle. The possible mechanisms responsible for the cardiac effects of propafenone and the therapeutic implications of these electrophysiological effects are discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4085559     DOI: 10.1016/0014-2999(85)90144-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

Review 1.  Adverse effects of class I antiarrhythmic drugs.

Authors:  J Caron; C Libersa
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

2.  Electrophysiological effects of E-3753, a new antiarrhythmic drug, in guinea-pig ventricular muscle.

Authors:  E Delpón; C Valenzuela; J Tamargo
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

Review 3.  Propafenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias.

Authors:  D W Harron; R N Brogden
Journal:  Drugs       Date:  1987-12       Impact factor: 9.546

4.  Stereoselective electrophysiological effects of propafenone in Langendorff perfused guinea pig hearts.

Authors:  U Stark; G Stark; K Stoschitzky; E Pilger; S Nagl; W Lindner; H A Tritthart
Journal:  Basic Res Cardiol       Date:  1992 Jan-Feb       Impact factor: 17.165

Review 5.  Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias.

Authors:  H M Bryson; K J Palmer; H D Langtry; A Fitton
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

6.  Effects of propafenone on 45Ca movements and contractile responses in vascular smooth muscle.

Authors:  R Carrón; F Pérez-Vizcaino; E Delpón; J Tamargo
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

Review 7.  New antiarrhythmic drugs in pediatric use: propafenone.

Authors:  T Paul; J Janousek
Journal:  Pediatr Cardiol       Date:  1994 Jul-Aug       Impact factor: 1.655

8.  Effects of 5-hydroxy-propafenone in guinea-pig atrial fibres.

Authors:  C Delgado; J Tamargo; T Tejerina; C Valenzuela
Journal:  Br J Pharmacol       Date:  1987-03       Impact factor: 8.739

9.  Effects of propafenone on calcium current in guinea-pig ventricular myocytes.

Authors:  C Delgado; J Tamargo; D Henzel; P Lorente
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

10.  Electrophysiological mechanism for the antiarrhythmic action of propafenone: a comparison with mexiletine.

Authors:  S Amerini; R Bernabei; P Carbonin; E Cerbai; A Mugelli; M Pahor
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.